Mergers & Acquisitions
Apr. 24, 2014
Corporate activist, acquirer team up to buy Irvine drugmaker with $45.6B offer
In an unusual alliance between an activist hedge fund and a corporate acquirer, Valeant Pharmaceuticals said it had joined forces with Pershing Square Capital Management to submit an unsolicited $45.6 billion buyout offer for Allergan.
Daily Journal Staff Writer
In a proposed deal that's forged a somewhat unusual alliance between an activist hedge fund and a corporate acquirer, Valeant Pharmaceuticals International Inc. formally announced on Tuesday that it had joined forces with Pershing Square Capital Management LP to submit an unsolicited $45.6 billion buyout offer for Irvine-based cosmetic drug maker Allergan Inc.
Six law firms are helping to pro...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In